| ID | 56073 |
| JaLCDOI | |
| FullText URL | |
| Author |
Morizane, Shin
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ouchida, Mamoru
Department of Molecular Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sunagawa, Ko
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sugimoto, Saeko
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kobashi, Mina
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Sugihara, Satoru
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nomura, Hayato
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tsuji, Kazuhide
Nishigawara Dermatology Clinic
Sato, Atsushi
Sato Dermatology Clinic
Miura, Yoshihiro
Miura Dermatology Clinic
Hattori, Hiroaki
Hattori Dermatology and Allergy Clinic
Tada, Kotaro
Tada Dermatology Clinic
Huh, Wook-Kang
Dr. Huh's Dermatology Clinic
Seno, Akemi
Department of Dermatology, Mitoyo General Hospital
Iwatsuki, Keiji
Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
|
| Abstract | Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is a large multidomain serine protease inhibitor that is expressed in epidermal keratinocytes. Nonsense mutations of the SPINK5 gene, which codes for LEKTI, cause Netherton syndrome, which is characterized by hair abnormality, ichthyosis, and atopy. A single nucleotide polymorphism (SNP) of SPINK5, p.K420E, is reported to be associated with the pathogenesis of atopic dermatitis (AD). We studied all 34 exons of the SPINK5 gene in Japanese 57 AD patients and 50 normal healthy controls. We detected nine nonsynonymous variants, including p.K420E; these variants had already been registered in the SNP database. Among them, p.R654H (n=1) was found as a heterozygous mutation in the AD patients, but not in the control. No new mutation was detected. We next compared the data of the AD patients with data from the Human Genetic Variation Database provided by Kyoto University; a significant difference was found in the frequency of the p.S368N genotype distribution. PolyPhen-2 and SIFT, two algorithms for predicting the functional effects of amino acid substitutions, showed significant scores for p.R654H. Therefore, R654H might be a risk factor for epidermal barrier dysfunction in some Japanese AD patients.
|
| Keywords | atopic dermatitis
SPINK5
LEKTI
serine protease inhibitor
epidermal barrier dysfunction
|
| Amo Type | Original Article
|
| Publication Title |
Acta Medica Okayama
|
| Published Date | 2018-06
|
| Volume | volume72
|
| Issue | issue3
|
| Publisher | Okayama University Medical School
|
| Start Page | 275
|
| End Page | 282
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| Content Type |
Journal Article
|
| language |
English
|
| Copyright Holders | CopyrightⒸ 2018 by Okayama University Medical School
|
| File Version | publisher
|
| Refereed |
True
|
| PubMed ID |